首页> 外文期刊>Cellular Physiology and Biochemistry >Delayed Ischemic Preconditioning Attenuated Renal Ischemia-Reperfusion Injury by Inhibiting Dendritic Cell Maturation
【24h】

Delayed Ischemic Preconditioning Attenuated Renal Ischemia-Reperfusion Injury by Inhibiting Dendritic Cell Maturation

机译:延迟缺血预处理通过抑制树突状细胞成熟来减轻肾缺血-再灌注损伤。

获取原文
获取外文期刊封面目录资料

摘要

Background/Aims Even though delayed ischemic preconditioning (DIPC) has been reported to produce renal protection, the underlying mechanism remains poorly understood. We reported that a 15-minute renal ischemic preconditioning (IPC) 4 days before subsequent ischemia-reperfusion attenuated renal injury Kidney dendritic cells (DCs) are abundant in the renal tubulointerstitium and, depending on their status, can induce immune activation or tolerance. The aim of the present study was to investigate the role of DCs in IPC of the kidney. Methods Mouse kidneys were challenged by transient brief episodes of sublethal ischemia followed by subsequent prolonged ischemia. DC abundance and maturation in the spleen and kidney were measured by flow cytometry and immunohistochemical staining. To confirm the function of mature DCs in the renoprotective effect of IPC on renal ischemia-reperfusion injury the A2 adenosine receptor (A2AR) antagonist SCH58261 was administered to stimulate DC maturation prior to assessment of renal functional and histological injury and the inflammatory reaction. Results Compared with sham-operated animals, preconditioned mice had a reduced injury with less CD11c+ cells, lower levels of the pro-inflammatory cytokine IL-17 and reduced expression of the mature DC marker CCR7. Preconditioned mice also produced more of the anti-inflammatory cytokine IL-10. Both renal cells and splenocytes from these mice had more DCs (CD45+/CD11c+/F4/80-), but fewer of these DCs were mature (CD45+/CD11c+/ F4/80-/MHC-II+/CD80+) compared with those from sham-treated animals, suggesting that the immunomodulatory effect of renal ischemic preconditioning is both local and systemic. Additionally, injection of the A2AR antagonist SCH58261 reversed IPC-induced inhibition of DC maturation and mitigated the protective effect of preconditioning, suggesting that DC maturation contributes to immune cell-mediated ischemic preconditioning. Conclusion Our results show that DIPC of the kidney provides local and systemic immunosuppression by inhibiting DC maturation and hence mediates a renal protective effect.
机译:背景/目的尽管据报道延迟缺血预处理(DIPC)能产生肾脏保护作用,但其潜在机制仍知之甚少。我们报告说,在随后的缺血再灌注减轻的肾损伤前4天进行15分钟的肾缺血预处理(IPC),肾小管间质中的肾脏树突状细胞(DCs)丰富,并且取决于它们的状态,可以诱导免疫激活或耐受。本研究的目的是研究DC在肾脏IPC中的作用。方法短暂性亚致死性短暂短暂发作继之以长期缺血,从而挑战小鼠肾脏。通过流式细胞术和免疫组织化学染色测量脾和肾中的DC丰度和成熟度。为了确认成熟DC在IPC对肾脏缺血再灌注损伤的肾脏保护作用中的功能,在评估肾功能和组织学损伤以及炎症反应之前,先给予A2腺苷受体(A2AR)拮抗剂SCH58261刺激DC成熟。结果与假手术动物相比,预处理小鼠的损伤减少,CD11c +细胞减少,促炎细胞因子IL-17的水平降低,而成熟DC标记物CCR7的表达降低。预处理的小鼠还产生更多的抗炎细胞因子IL-10。与假手术组相比,这些小鼠的肾细胞和脾细胞均具有更多的DC(CD45 + / CD11c + / F4 / 80-),但这些DCs成熟的较少(CD45 + / CD11c + / F4 / 80- / MHC-II + / CD80 +)。 -治疗的动物,表明肾缺血预处理的免疫调节作用是局部的和全身的。此外,注射A2AR拮抗剂SCH58261可逆转IPC诱导的DC成熟抑制并减轻预处理的保护作用,表明DC成熟有助于免疫细胞介导的缺血预处理。结论我们的结果表明,肾脏的DIPC通过抑制DC成熟来提供局部和全身免疫抑制作用,从而介导肾脏保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号